Product NDC: | 10237-741 |
Proprietary Name: | Orajel for Cold Sores |
Non Proprietary Name: | Benzalkonium Chloride, Benzocaine |
Active Ingredient(s): | .13; .5 mg/mL; mg/mL & nbsp; Benzalkonium Chloride, Benzocaine |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10237-741 |
Labeler Name: | Church & Dwight Co., Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part356 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20120701 |
Package NDC: | 10237-741-04 |
Package Description: | 2 VIAL in 1 PACKAGE (10237-741-04) > .6 mL in 1 VIAL |
NDC Code | 10237-741-04 |
Proprietary Name | Orajel for Cold Sores |
Package Description | 2 VIAL in 1 PACKAGE (10237-741-04) > .6 mL in 1 VIAL |
Product NDC | 10237-741 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Benzalkonium Chloride, Benzocaine |
Dosage Form Name | LIQUID |
Route Name | TOPICAL |
Start Marketing Date | 20120701 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Church & Dwight Co., Inc. |
Substance Name | BENZALKONIUM CHLORIDE; BENZOCAINE |
Strength Number | .13; .5 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes |